Vertex Pharmaceuticals Incorporated
VRTX Healthcare Biotechnology
Vertex Pharmaceuticals Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $12.0 billion, up 8.90% from fiscal 2024. In the quarter to June 2026, revenue grew 12.5%, EPS grew 7.96% and free cash flow grew 9.25%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years.
Follow VRTX
Vertex Pharmaceuticals Incorporated (VRTX) Operating margin
Vertex Pharmaceuticals Incorporated's operating margin over the twelve months to 30 June 2026 was 38.0%, up 3.2 percentage points from fiscal 2025 (34.8%). Over the past ten years it has ranged from −45.2% (fiscal 2015) to 48.2% (fiscal 2022); the current reading is higher than 64% of that period. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 34.8% | 36.88 |
| FY2024 | −2.11% | (40.94) |
| FY2023 | 38.8% | (9.40) |
| FY2022 | 48.2% | 11.50 |
| FY2021 | 36.7% | (9.30) |
| FY2020 | 46.0% | 17.26 |
| FY2019 | 28.8% | 7.93 |
| FY2018 | 20.8% | 15.89 |
| FY2017 | 4.95% | 4.37 |
| FY2016 | 0.58% | 45.81 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 37.4% | (0.70) |
| Mar 2026 | 38.1% | 0.30 |
| Dec 2025 | 37.8% | (0.76) |
| Sep 2025 | 38.6% | (0.27) |
| 42 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| RPRX Royalty Pharma PLC compare | 59.6% |
| VRTX Vertex Pharmaceuticals Incorporated | 38.0% |
| ARGX argenex SE compare | 30.1% |
| REGN Regeneron Pharmaceuticals, Inc. compare | 24.7% |
| ALNY Alnylam Pharmaceuticals, Inc. compare | 20.8% |
| ONC BeOne Medicines Ltd. - Sponsored ADR compare | 15.1% |
| RVMD Revolution Medicines, Inc. compare | 0.00% |
| MRNA Moderna, Inc. compare | −149.0% |
| ROIV Roivant Sciences Ltd. compare | −7,914.8% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on VRTX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement